AIMMUNE THERAPEUTICS INC's ticker is and the CUSIP is 00900T957. A total of 4 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $0 | – | 434 | +100.9% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 216 | +52.1% | 0.00% | – |
| Q1 2020 | $204,000 | -7.3% | 142 | +115.2% | 0.00% | – |
| Q4 2019 | $220,000 | -71.2% | 66 | -81.9% | 0.00% | -100.0% |
| Q3 2019 | $764,000 | +932.4% | 365 | +913.9% | 0.00% | – |
| Q2 2019 | $74,000 | -1.3% | 36 | +5.9% | 0.00% | – |
| Q1 2019 | $75,000 | +66.7% | 34 | +78.9% | 0.00% | – |
| Q4 2018 | $45,000 | -60.5% | 19 | -54.8% | 0.00% | – |
| Q3 2018 | $114,000 | -33.7% | 42 | -34.4% | 0.00% | -100.0% |
| Q2 2018 | $172,000 | +290.9% | 64 | -53.6% | 0.00% | -50.0% |
| Q1 2018 | $44,000 | +388.9% | 138 | +1154.5% | 0.00% | – |
| Q4 2017 | $9,000 | +800.0% | 11 | -35.3% | 0.00% | – |
| Q3 2017 | $1,000 | -66.7% | 17 | -43.3% | 0.00% | – |
| Q3 2016 | $3,000 | – | 30 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 600 | $12,000 | 0.00% |
| SIMPLEX TRADING, LLC | 36 | $74,000 | 0.00% |
| JPMORGAN CHASE & CO | 35,000 | $697,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |